Nasal application of fentanyl citrate as symptom control against breathlessness in palliative care - Overview and case report;Nasale anwendung von fentanylzitrat zur kupierung von atemnot in der palliativversorgung - überblick und fallbeispie

Wiener Medizinische Wochenschrift

Volumn 159, Issue 23-24, 2009, Pages 566-570

  Sitte, Thomas ^a  

^a PalliativNetz Osthessen   (Germany)

Author keywords

Dyspnoea; Fentanyl; Home care; Nasal; Symptom control

Indexed keywords

FENTANYL CITRATE;

ADULT; AGED; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DYSPNEA; HOME CARE; HUMAN; LUNG CARCINOMA; PALLIATIVE THERAPY; SEDATION;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRANASAL; AGED, 80 AND OVER; AMBULATORY CARE; ANALGESICS, OPIOID; CARCINOMA, BRONCHOGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSPNEA; FENTANYL; HOME CARE SERVICES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TERMINAL CARE; TREATMENT OUTCOME;

EID: 77949456685     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-009-0724-2     Document Type: Article

References (32)

1. M Kern E Ostgathe H Wessel 2007 Ambulante palliative Betreuung in Bonn - Einflussfaktoren auf eine stationäre Einweisung am Lebensende Z f Palliativmedizin 8 155 161 10.1055/s-2007-986261
2. Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. [Review] [70 refs]. Cochrane Database of Systematic Reviews (4):CD002066, 2001
3. AP CD Abernethy P Frith BS Fazekas A McHugh B Chuong 2003 Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 523 528 10.1136/bmj.327.7414. 523 1:CAS:528:DC%2BD3sXotVehsrk%3D 12958109
4. A Qaseem V Snow P Shekelle D Casey T Cross D Owens 2008 Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians Ann Intern Med 148 141 146 18195338
5. Burburan SM. Effect of nebulized fentanyl in patients with refractory dyspnea. Vortrag EAPC, Wien, 2009
6. T Sitte C Bausewein 2008 Intranasal fentanyl for episodic breathlessness J Pain Symptom Manage 36 3 6 10.1016/j.jpainsymman.2008.08.002
7. KE Clemens E Klaschik 2007 Diagnostik und Therapie der Atemnot in der Palliativmedizin Z Palliativmed 8 141 154 10.1055/s-2007-986254
8. PJ Coyne R Viswanathan TJ Smith 2002 Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea J Pain Symptom Manage 23 157 160 10.1016/S0885-3924(01)00391-8 1:CAS:528:DC%2BD38Xns1ahtb4%3D 11844637 (Pubitemid 34158649)
9. MA Benitez-Rosario AS Martin M Feria 2005 Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients J Pain Symptom Manage 30 395 397 10.1016/j.jpainsymman.2005.10.002 16310612 (Pubitemid 41718958)
10. Arzneimittelkommission d. Deutschen Apotheker. Neues Rezeptur-Formularium (NRF). Eschborn, Govi-Verlag. ISBN-10: 3774100101
11. O Dale R Hjortkjaer ED Kharasch 2002 Nasal administration of opioids for pain management in adults Acta Anaesthesiol Scand 46 7 759 770 10.1034/j.1399-6576.2002.460702.x 1:STN:280:DC%2BD38vktFSlug%3D%3D 12139528
12. G Zeppetella 2000 An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study J Pain Symptom Manage 20 253 258 10.1016/S0885-3924(00)00180-9 1:STN:280:DC%2BD3M%2FkvVWksg%3D%3D 11027906
13. MA Sarkar 1992 Drug metabolism in the nasal mucosa Pharm Res 9 1 9 10.1023/A:1018911206646 1:CAS:528:DyaK38XnsFGnuw%3D%3D 1589391
14. A Takala V Kaasalainen T Seppala E Kalso KT Olkkola 1997 Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone Acta Anaesthesiol Scand 41 309 312 10.1111/j.1399-6576.1997.tb04684.x 1:STN:280:DyaK2s3hs1eluw%3D%3D 9062618
15. J Eriksen NH Jensen M Kamp-Jensen H Bjarno P Friis D Brewster 1989 The systemic availability of buprenorphine administered by nasal spray J Pharm Pharmacol 41 803 805 1:CAS:528:DyaK3cXhtFymtw%3D%3D 2576057
16. HW Striebel J Kramer I Luhmann I Rohierse-Hohler A Rieger 1993 [Pharmacokinetics of intranasal Fentanyl.] Schmerz 7 122 125 10.1007/BF02527870 1:STN:280:DC%2BD1c3lsVersQ%3D%3D 18415433
17. S Lim MJ Paech B Sunderland MJ Robert SL Banks MWM Rucklidge 2003 Pharmacokinetics of nasal fentanyl J Pharm Pract Res 33 1 59 63
18. O Dale R Hjortkjaer ED Kharasch 2002 Nasal administration of opioids for pain management in adults Acta Anaesthesiol Scand 46 759 770 10.1034/j.1399-6576.2002.460702.x 1:STN:280:DC%2BD38vktFSlug%3D%3D 12139528
19. HW Striebel D Koenigs J Kramer 1992 Postoperative pain management by intranasal demand-adapted fentanyl titration Anesthesiology 77 281 285 10.1097/00000542-199208000-00010 1:STN:280:DyaK38zlt1Sksw%3D%3D 1642347
20. G Zeppetella 2000 An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study J Pain Symptom Manage 20 253 258 10.1016/S0885-3924(00)00180-9 1:STN:280:DC%2BD3M%2FkvVWksg%3D%3D 11027906
21. T Sitte C Bausewein 2008 Intranasal fentanyl for episodic breathlessness J Pain Symptom Manage 36 3 6 10.1016/j.jpainsymman.2008.08.002
22. LL Christrup D Foster LD Popper T Troen R Upton 2008 Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study Clin Ther 30 469 481 10.1016/j.clinthera.2008.03.001 1:CAS:528:DC%2BD1cXhtVWltLfN 18405786
23. ®: efficacy, tolerability and onset of action in the treatment of Breakthrough Cancer Pain (BTCP). Posterbeitrag, Jahrestagung APS 5/2009
24. R George C Regnard 2007 Lethal opioids or dangerous prescribers Pall Med 21 77 80 10.1177/0269216307076714 (Pubitemid 46455832)
25. Clemens K, Klaschik E. Sauerstoffinsufflation versus Opiodapplikation bei Dyspnoe. Posterbeitrag. Palliativkongress 2008, Wiesbaden
26. Wiese C, Bartels U, Nauck F, Graf B, Hanekop G. Notärztliche Behandlung von Palliativpatienten im weit fortgeschrittenen Krankheitsstadium mit Dyspnoe. Posterbeitrag, Palliativkongress 2008, Wiesbaden
27. M Kern E Ostgathe H Wessel 2007 Ambulante palliative Betreuung in Bonn - Einflussfaktoren auf eine stationäre Einweisung am Lebensende Z f Palliativmedizin 8 155 161 10.1055/s-2007-986261
28. Waldvogel HH. Analgetika, Antinozizeptiva, Adjuvantien. Handbuch für die Schmerztherapie. Springer, Berlin Heidelberg New York, 2004
29. ®, 2008
30. ®, 2008
31. ®, 2009
32. ®, 2009